To search for clinical trials and detailed information on products in development, visit our Prevention Research & Development Database
showing 1-10 of 772
A call to action for faith leaders from across the region to join in solidarity in defense of human rights and evidence-based HIV prevention, including for vulnerable populations.
This roadmap outlines a strategy for the equitable expression and delivery of HIV prevention services to key populations (KPs) globally and regionally. It introduces a critical, coordinated approach led by KPs to accelerate the implementation of existing and new HIV prevention interventions.
Join AVAC and partners for the biennial International Conference on AIDS and Sexually Transmitted Infections (ICASA), in Harare, Zimbabwe, December 4-9.
In the pursuit of a future without HIV and AIDS, voluntary medical male circumcision (VMMC) remains an integral component of the arsenal in HIV prevention, offering a cost-effective and scientifically proven intervention that holds immense potential in curbing the acquisition of HIV.
As we look back on 2023, powerful cross currents confront HIV prevention and global health equity. More options than ever before could be available, but many forces threaten to undermine access to proven prevention options that exist today and the development of additional options that are still needed. Threats to PEPFAR and hate laws targeting LBGTQI+ people are just a sample.
Tuesday, November 28 at 7:00 AM ET Moderator: Richard Muko, Regional Implementation Advocacy Manager, AVAC Panelists: Joan Chamungu, Tanzanian Network of Women Living with HIV, Lawrence Khonyongwa, Malawi Network of People of Living with...
The Pandemic Accord negotiations are ongoing, and should come to fruition next year. What do they mean for your work, your country, and the future of global health? On Tuesday, November 21, 8:00 to 9:30 AM EST / 2:00 to 3:30 PM CEST, advocates came...
Tuesday, November 28 Between the recent accelerated growth in global PrEP initiations, and the introduction of new PrEP products like cabotegravir and the dapivirine vaginal ring, the field of PrEP data has never been more exciting or more...
This timeline shows the potential time points when the next-generation of HIV prevention options might find their way into new programs.
PEPFAR’s role has been instrumental to accelerating global uptake of PrEP to date. This lifesaving program must see continued full funding and a 5-year reauthorization to carry on this work and help to put the world on track to control the epidemic.
showing 1-10 of 772